Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Biogen Inc (BIIB)

Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
PANL
3 Value Stocks Walking a Fine Line StockStory - Wed Feb 18, 10:37PM CST

3 Value Stocks Walking a Fine Line

PANL : 8.93 (-1.11%)
WEX : 156.74 (+1.31%)
BIIB : 191.68 (-0.21%)
Biogen Inc logo on HQ-by Tada Images via Shutterstock
What Are Wall Street Analysts' Target Price for Biogen Stock? Barchart - Mon Feb 16, 5:17AM CST

Analysts are maintaining a generally positive outlook on Biogen's shares, noting recent stock strength and solid operational results.

$SPX : 6,870.08 (+0.12%)
IBB : 173.49 (-0.88%)
BIIB : 191.68 (-0.21%)
BIIB
The 5 Most Interesting Analyst Questions From Biogen’s Q4 Earnings Call StockStory - Thu Feb 12, 11:36PM CST

The 5 Most Interesting Analyst Questions From Biogen’s Q4 Earnings Call

BIIB : 191.68 (-0.21%)
BIIB
1 Unpopular Stock That Deserves a Second Chance and 2 We Find Risky StockStory - Thu Feb 12, 10:41PM CST

1 Unpopular Stock That Deserves a Second Chance and 2 We Find Risky

ASGN : 44.76 (+0.61%)
ALHC : 20.45 (-1.87%)
BIIB : 191.68 (-0.21%)
Biogen Announces Board Chair Transition GlobeNewswire - Wed Feb 11, 4:00PM CST

CAMBRIDGE, Mass., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Biogen Inc . (Nasdaq: BIIB) today announced that the Board of Directors has elected Dr. Maria C. Freire as Chair of the Board of Directors, effective...

BIIB : 191.68 (-0.21%)
BIIB
BIIB Q4 Deep Dive: Pipeline Advances and New Product Launches Offset Legacy Headwinds StockStory - Fri Feb 6, 11:31PM CST

BIIB Q4 Deep Dive: Pipeline Advances and New Product Launches Offset Legacy Headwinds

BIIB : 191.68 (-0.21%)
BIIB
Biogen’s (NASDAQ:BIIB) Q4 CY2025: Strong Sales StockStory - Fri Feb 6, 6:17AM CST

Biogen’s (NASDAQ:BIIB) Q4 CY2025: Strong Sales

BIIB : 191.68 (-0.21%)
Wall street sign in New York with New York Stock Exchange background by Stuart Monk via Shutterstock
Stock Index Futures Climb After Tech Rout, Amazon Slips on CapEx Blowout Barchart - Fri Feb 6, 5:28AM CST

March S&P 500 E-Mini futures (ESH26) are up +0.58%, and March Nasdaq 100 E-Mini futures (NQH26) are up +0.69% this morning, rebounding after days of heavy selling as investors stepped in to buy the dip....

MARA : 8.12 (+2.01%)
MSTR : 133.37 (+3.03%)
NVDA : 187.71 (-0.10%)
AVGO : 334.92 (+0.28%)
BE : 156.01 (-1.88%)
KOG.O.DX : 396.950 (+1.01%)
MOH : 146.85 (-0.94%)
STLAP.FP : 6.578 (+2.49%)
MU : 422.78 (+1.30%)
ESH26 : 6,896.75 (+0.29%)
MSFT : 397.03 (-0.36%)
NOVOB.C.DX : 300.200 (-1.88%)
BIIB
Biogen (BIIB) Reports Q4: Everything You Need To Know Ahead Of Earnings StockStory - Wed Feb 4, 9:02PM CST

Biogen (BIIB) Reports Q4: Everything You Need To Know Ahead Of Earnings

BIIB : 191.68 (-0.21%)
Stoke Therapeutics to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 Business Wire - Wed Feb 4, 3:01PM CST

Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine,...

STOK : 34.35 (-0.06%)
BIIB : 191.68 (-0.21%)

Barchart Exclusives

Anthropic’s CEO Warns Humans Face a ‘Critical Test as a Species’ as AI Ramps Up. What’s Behind the Stark Message? Barchart - 3 minutes ago
Dario Amodei has warned that unchecked AI poses a systematic risk to society. To keep our institutions running, companies and governments need to develop better guardrails. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot